FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2911664474> ?p ?o ?g. }

• W2911664474 abstract "Medications used to treat inflammatory bowel disease (IBD) have significantly improved patient outcomes and delayed time to surgery. However, some of these therapies are recognized to increase the general risk of infection and have an unclear impact on postoperative infection risk.To assess the impact of perioperative IBD medications on the risk of postoperative infections within 30 days of surgery.We searched the Cochrane IBD Group's Specialized Register (29 October 2019), MEDLINE (January 1966 to October 2019), Embase (January 1985 to October 2019), the Cochrane Library, ClinicalTrials.gov and the WHO International Clinical Trials Registry Platform from inception up to October 2019, and reference lists of articles.Randomized controlled trials, quasi-randomized controlled trials, non-randomized controlled trials, prospective cohort studies, retrospective cohort studies, case-control studies and cross-sectional studies comparing participants treated with an IBD medication preoperatively or within 30 days postoperatively to those who were not taking that medication (either another active medication, placebo, or no treatment). We included published study reports and abstracts.Two review authors independently screened titles and abstracts and extracted data. The primary outcome was postoperative infection within 30 days of surgery. Secondary outcomes included incisional infections and wound dehiscence, intra-abdominal infectious complications and extra-abdominal infections. Three review authors assessed risks of bias using the Newcastle-Ottawa Scale. We contacted authors for additional information when data were missing. For the primary and secondary outcomes, we calculated odds ratios (ORs) and corresponding 95% confidence intervals (95% CIs) using the generic inverse variance method. When applicable, we analyzed adjusted and unadjusted data separately. We evaluated the certainty of the evidence using GRADE.We included 68 observational cohort studies (total number of participants unknown because some studies did not report the number of participants). Of these, 48 studies reported including participants with Crohn's disease, 36 reported including participants with ulcerative colitis and five reported including participants with indeterminate colitis. All 42 studies that reported urgency of surgery included elective surgeries, with 31 (74%) of those also including emergency surgeries. Twenty-four studies had low risk of bias while the rest had very high risk. Based on pooling of adjusted data, we calculated ORs for postoperative total infection rates in participants who received corticosteroids (OR 1.70, 95% CI 1.38 to 2.09; low-certainty evidence), immunomodulators (OR 1.29, 95% CI 0.95 to 1.76; low-certainty evidence), anti-TNF agents (OR 1.60, 95% CI 1.20 to 2.13; very low-certainty evidence) and anti-integrin agents (OR 1.04, 95% CI 0.79 to 1.36; low-certainty evidence). We pooled unadjusted data to assess postoperative total infection rates for the use of aminosalicylates (5-ASA) (OR 0.76, 95% CI 0.51 to 1.14; very low-certainty evidence). One secondary outcome examined was wound-related complications in participants using: corticosteroids (OR 1.41, 95% CI 0.72 to 2.74; very low-certainty evidence), immunomodulators (OR 1.35, 95% CI 0.96 to 1.89; very low-certainty evidence), anti-TNF agents (OR 1.18, 95% CI 0.83 to 1.68; very low-certainty evidence) and anti-integrin agents (OR 1.64, 95% CI 0.77 to 3.50; very low-certainty evidence) compared to controls. Another secondary outcome examined the odds of postoperative intra-abdominal infections in participants using: corticosteroids (OR 1.53, 95% CI 1.28 to 1.84; very low-certainty evidence), 5-ASA (OR 0.77, 95% CI 0.45 to 1.33; very low-certainty evidence), immunomodulators (OR 0.86, 95% CI 0.66 to 1.12; very low-certainty evidence), anti-TNF agents (OR 1.38, 95% CI 1.04 to 1.82; very low-certainty evidence) and anti-integrin agents (OR 0.40, 95% CI 0.14 to 1.20; very low-certainty evidence) compared to controls. Lastly we checked the odds for extra-abdominal infections in participants using: corticosteroids (OR 1.23, 95% CI 0.97 to 1.55; very low-certainty evidence), immunomodulators (OR 1.17, 95% CI 0.80 to 1.71; very low-certainty evidence), anti-TNF agents (OR 1.34, 95% CI 0.96 to 1.87; very low-certainty evidence) and anti-integrin agents (OR 1.15, 95% CI 0.43 to 3.08; very low-certainty evidence) compared to controls.The evidence for corticosteroids, 5-ASA, immunomodulators, anti-TNF medications and anti-integrin medications was of low or very low certainty. The impact of these medications on postoperative infectious complications is uncertain and we can draw no firm conclusions about their safety in the perioperative period. Decisions on preoperative IBD medications should be tailored to each person's unique circumstances. Future studies should focus on controlling for potential confounding factors to generate higher-quality evidence." @default.
• W2911664474 created "2019-02-21" @default.
• W2911664474 creator A5001603511 @default.
• W2911664474 creator A5008693009 @default.
• W2911664474 creator A5029349829 @default.
• W2911664474 creator A5037978423 @default.
• W2911664474 creator A5046354872 @default.
• W2911664474 creator A5062237794 @default.
• W2911664474 date "2020-10-24" @default.
• W2911664474 modified "2023-10-13" @default.
• W2911664474 title "Risk of postoperative infectious complications from medical therapies in inflammatory bowel disease" @default.
• W2911664474 cites W1557244150 @default.
• W2911664474 cites W1569973728 @default.
• W2911664474 cites W1593231251 @default.
• W2911664474 cites W1601689129 @default.
• W2911664474 cites W1644352796 @default.
• W2911664474 cites W1801183899 @default.
• W2911664474 cites W1937908244 @default.
• W2911664474 cites W1948509343 @default.
• W2911664474 cites W1970270841 @default.
• W2911664474 cites W1978842131 @default.
• W2911664474 cites W1981753627 @default.
• W2911664474 cites W1985653091 @default.
• W2911664474 cites W1987428209 @default.
• W2911664474 cites W1987457383 @default.
• W2911664474 cites W1990111548 @default.
• W2911664474 cites W1990220938 @default.
• W2911664474 cites W1990864861 @default.
• W2911664474 cites W1991151307 @default.
• W2911664474 cites W1995605870 @default.
• W2911664474 cites W1996580168 @default.
• W2911664474 cites W1996835391 @default.
• W2911664474 cites W2002145441 @default.
• W2911664474 cites W2003226689 @default.
• W2911664474 cites W2006394992 @default.
• W2911664474 cites W2014960186 @default.
• W2911664474 cites W2018073324 @default.
• W2911664474 cites W2021795939 @default.
• W2911664474 cites W2022322730 @default.
• W2911664474 cites W2025059586 @default.
• W2911664474 cites W2026267556 @default.
• W2911664474 cites W2026679422 @default.
• W2911664474 cites W2026766129 @default.
• W2911664474 cites W2030662008 @default.
• W2911664474 cites W2034126900 @default.
• W2911664474 cites W2034640189 @default.
• W2911664474 cites W2035049298 @default.
• W2911664474 cites W2037283201 @default.
• W2911664474 cites W2044181146 @default.
• W2911664474 cites W2048226068 @default.
• W2911664474 cites W2052189184 @default.
• W2911664474 cites W2064256615 @default.
• W2911664474 cites W2064445313 @default.
• W2911664474 cites W2064770992 @default.
• W2911664474 cites W2065303751 @default.
• W2911664474 cites W2071059330 @default.
• W2911664474 cites W2080410907 @default.
• W2911664474 cites W2080610863 @default.
• W2911664474 cites W2083533774 @default.
• W2911664474 cites W2083987164 @default.
• W2911664474 cites W2090619685 @default.
• W2911664474 cites W2092326080 @default.
• W2911664474 cites W2093548935 @default.
• W2911664474 cites W2093872664 @default.
• W2911664474 cites W2099822835 @default.
• W2911664474 cites W2104600285 @default.
• W2911664474 cites W2119986033 @default.
• W2911664474 cites W2121211166 @default.
• W2911664474 cites W2122527047 @default.
• W2911664474 cites W2124734013 @default.
• W2911664474 cites W2126398097 @default.
• W2911664474 cites W2127838352 @default.
• W2911664474 cites W2127958001 @default.
• W2911664474 cites W2136032632 @default.
• W2911664474 cites W2142082253 @default.
• W2911664474 cites W2143321354 @default.
• W2911664474 cites W2148568201 @default.
• W2911664474 cites W2149733353 @default.
• W2911664474 cites W2151113382 @default.
• W2911664474 cites W2155483619 @default.
• W2911664474 cites W2157503011 @default.
• W2911664474 cites W2165010366 @default.
• W2911664474 cites W2176682597 @default.
• W2911664474 cites W2182578492 @default.
• W2911664474 cites W2252490034 @default.
• W2911664474 cites W2254314522 @default.
• W2911664474 cites W2276190964 @default.
• W2911664474 cites W2324379603 @default.
• W2911664474 cites W2327167772 @default.
• W2911664474 cites W2328041186 @default.
• W2911664474 cites W2328481297 @default.
• W2911664474 cites W2329732771 @default.
• W2911664474 cites W2333515853 @default.
• W2911664474 cites W2336681533 @default.
• W2911664474 cites W2338659337 @default.
• W2911664474 cites W2342223687 @default.
• W2911664474 cites W2460401980 @default.
• W2911664474 cites W2512023138 @default.
• W2911664474 cites W2513279438 @default.
• W2911664474 cites W2523696841 @default.

• next